what are the potential side effects of glp-1 drugs Your guide to GLP-1 nausea: How to handle

Wang RF, Xue GF, Hlscher C, Tian MJ, Feng P, Zheng JY, et al

Healthcare systems are more focused on newer therapeutic approaches that not only control blood glucose but also target linked comorbidities

Evers said the Pharmacare program in the majority of provinces, including in Atlantic Canada, does not cover the cost of GLP-1 drugs for obesity because it has not yet been recognized as a chronic disease

For a 220-pound person, that is roughly 11-22 pounds with phentermine versus 35-50 pounds with tirzepatide

Glucagon like peptide 1 receptor agonists in the treatment of obesity

GLP-1R as a potential link between diabetes and Alzheimers disease: Mechanistic insights and therapeutic opportunities